Amgen secures FDA approval for Remicade biosimilar AVSOLA
AVSOLA is an anti-tumour necrosis factor alpha (anti-TNF) monoclonal antibody, which is very similar to Remicade and has…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
09 Dec 19
AVSOLA is an anti-tumour necrosis factor alpha (anti-TNF) monoclonal antibody, which is very similar to Remicade and has…
05 Dec 19
Healthcare firm Novartis and AWS will jointly develop ‘Insight Centres’ to provide real-time visibility across the network of…
Dell Medical School was opened in 2016 at UT Austin and received $50m in funding from the Michael…
03 Dec 19
Covering an area of 65,000ft², Lilly Gateway Labs will provide 32 advanced private lab modules — with lab…
03 Dec 19
Seprafilm Adhesion Barrier is intended to reduce the incidence, extent and severity of postoperative adhesions between the abdominal…
02 Dec 19
The Serena Bright facilitates breast biopsy exams to be performed in the same room, with the same mammography…
29 Nov 19
Novartis will manufacture Kymriah and other CAR-T cell therapies and gene therapies at the new factory
29 Nov 19
The FDA has accepted AstraZeneca’s sBLA for Imfinzi based on positive results from the phased III CASPIAN trial
28 Nov 19
The acquisition forms part of Asahi Kasei’s plan to accelerate its transformation into a global healthcare company
27 Nov 19
EOSedge to be unveiled at the RSNA 2019 Annual Meeting next month